$102.75
-0.39-0.38%
In chiusura: -
$102.75
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Boston Scientific segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
ott 22
Stima EPS
$0.698
Stima dei ricavi trimestrali
$4.86B
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$18.49B
Analizza lo storico degli utili di Boston Scientific utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
BSX | Boston Scientific | $0.63 | $0.70 | — | — | $4.21B | $4.86B | — | — | 10/22/2025 | |
BSX | Boston Scientific | $0.62 | $0.72 | $0.75 | 4.17% | $4.12B | $4.89B | $5.06B | 3.47% | 07/23/2025 | |
BSX | Boston Scientific | $0.56 | $0.67 | $0.75 | 11.94% | $3.86B | $4.57B | $4.66B | 2.04% | 04/23/2025 | |
BSX | Boston Scientific | $0.55 | $0.66 | $0.70 | 6.06% | $3.73B | $4.42B | $4.56B | 3.19% | 02/05/2025 | |
BSX | Boston Scientific | $0.50 | $0.59 | $0.63 | 6.78% | $3.53B | $4.04B | $4.21B | 4.18% | 10/23/2024 | |
BSX | Boston Scientific | $0.53 | $0.58 | $0.62 | 6.90% | $3.60B | $4.02B | $4.12B | 2.49% | 07/24/2024 | |
BSX | Boston Scientific | $0.47 | $0.51 | $0.56 | 9.80% | $3.39B | $3.69B | $3.86B | 4.50% | 04/24/2024 | |
BSX | Boston Scientific | $0.45 | $0.51 | $0.55 | 7.84% | $3.24B | $3.59B | $3.73B | 3.76% | 01/31/2024 | |
BSX | Boston Scientific | $0.43 | $0.48 | $0.50 | 4.17% | $3.17B | $3.47B | $3.53B | 1.64% | 10/26/2023 | |
BSX | Boston Scientific | $0.44 | $0.49 | $0.53 | 8.16% | $3.24B | $3.50B | $3.60B | 2.83% | 07/27/2023 | |
BSX | Boston Scientific | $0.39 | $0.43 | $0.47 | 9.30% | $3.03B | $3.16B | $3.39B | 7.25% | 04/26/2023 | |
BSX | Boston Scientific | $0.45 | $0.47 | $0.45 | -4.26% | $3.13B | $3.24B | $3.24B | 0.06% | 02/01/2023 | |
BSX | Boston Scientific | $0.41 | $0.44 | $0.43 | -2.27% | $2.93B | $3.15B | $3.17B | 0.63% | 10/26/2022 | |
BSX | Boston Scientific | $0.40 | $0.42 | $0.44 | 4.76% | $3.08B | $3.22B | $3.24B | 0.75% | 07/27/2022 | |
BSX | Boston Scientific | $0.37 | $0.39 | $0.39 | 0.00% | $2.75B | $2.95B | $3.03B | 2.58% | 04/27/2022 | |
BSX | Boston Scientific | $0.23 | $0.44 | $0.45 | 2.27% | $2.71B | $3.11B | $3.13B | 0.55% | 02/02/2022 | |
BSX | Boston Scientific | $0.37 | $0.40 | $0.41 | 2.50% | $2.66B | $2.97B | $2.93B | -1.28% | 10/27/2021 | |
BSX | Boston Scientific | $0.08 | $0.37 | $0.40 | 8.11% | $2.00B | $2.94B | $3.08B | 4.66% | 07/27/2021 | |
BSX | Boston Scientific | $0.28 | $0.31 | $0.37 | 19.35% | $2.54B | $2.62B | $2.75B | 5.04% | 04/28/2021 | |
BSX | Boston Scientific | $0.46 | $0.31 | $0.23 | -25.81% | $2.90B | $2.83B | $2.71B | -4.31% | 02/03/2021 | |
BSX | Boston Scientific | $0.39 | $0.25 | $0.37 | 48.00% | $2.71B | $2.52B | $2.66B | 5.52% | 10/28/2020 |
Boston Scientific (BSX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-07-23 | $0.75 | $0.72 | 4.17 % |
| Q1 | 2025-04-23 | $0.75 | $0.67 | 11.9 % |
| Q4 | 2025-02-05 | $0.70 | $0.66 | 6.06 % |
| Q3 | 2024-10-23 | $0.63 | $0.59 | 6.78 % |
Boston Scientific (BSX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-07-23 | $5.06B | $4.89B | 3.47 % |
| Q1 | 2025-04-23 | $4.66B | $4.57B | 2.04 % |
| Q4 | 2025-02-05 | $4.56B | $4.42B | 3.19 % |
| Q3 | 2024-10-23 | $4.21B | $4.04B | 4.18 % |
FAQ
Quando Boston Scientific (NYSE:BSX) riporterà gli utili?
Si prevede che Boston Scientific (BSX) fornisca risultati il ottobre 22, 2025. Gli ultimi risultati sono stati pubblicati il luglio 23, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Boston Scientific (NYSE:BSX)?
L'EPS effettivo era $0.75, che superato la stima di $0.72.
Quali sono state le entrate di Boston Scientific (NYSE:BSX)?
Le entrate effettive sono state $5.1B, che superato la stima di $4.9B.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.